Comparison: ARA-290 Stacking Protocols by Research Goal
ARA-290 + BPC-157 IRR anti-inflammatory + VEGF angiogenesis and axonal growth ARA-290 4mg/day, BPC-157 500mcg twice daily ARA-290 morning, BPC-157 afternoon/evening (4–6 hour gap) Neuropathy, nerve injury, diabetic complications …